The present invention relates generally to electroporation of tissues and, specifically, to apparatus and methods for reducing subcutaneous fat deposits, performing virtual face lifts, and body sculpturing.
“Cosmetic surgery” is a phrase used to describe broadly surgical changes made to a human body with the usual, though not always, justification of enhancing appearance. This area of medical practice constitutes an ever-growing industry around the world. Obviously, where such a procedure fails to deliver an enhanced appearance, the procedure fails to meet the desired goal. One of the reasons that the majority of current procedures fail to deliver upon their promise is that, for the most part, current procedures are invasive, requiring incisions and suturing, and can have serious and unpleasant side effects, including but not limited to scarring, infection, and loss of sensation.
One of the more common forms of cosmetic surgery is the “face-lift.” A face-lift is intended to enhance facial appearance by removing excess facial skin and tightening the remaining skin, thus removing wrinkles. A face-lift is traditionally performed by cutting and removing portions of the skin and underlying tissues on the face and neck. Two incisions are made around the ears and the skin on the face and neck is separated from the subcutaneous tissues. The skin is stretched, excess tissue and skin are removed by cutting with a scissors or scalpel, and the skin is pulled back and sutured around the ears. The tissue tightening occurs after healing of the incisions because less skin covers the same area of the face and neck and also because of the scars formed on the injured areas are contracting during the healing process.
Traditional face-lift procedures are not without potential drawbacks and side effects. One drawback of traditional cosmetic surgery is related to the use of scalpel and scissors. The use of these devices sometimes leads to significant bleeding, nerve damage, possible infection and/or lack of blood supply to some areas on the skin after operation. Discoloration of the skin, alopecia (boldness), is another possible side effect of the standard cosmetic surgery. The overall quality of the results of the surgery is also sometimes disappointing to the patients because of possible over-corrections, leading to undesired changes in the facial expression. Additionally, face-lift procedures require a long recovery period before swelling and bruising subside.
The use of lasers to improve the appearance of the skin has been also developed. Traditional laser resurfacing involves application of laser radiation to the external layer of the skin—the epidermis. Destruction of the epidermis leads to rejuvenation of the epidermis layer. The drawback of the laser resurfacing procedure is possible discoloration of the skin (red face) that can be permanent.
Another laser procedure involves using optical fibers for irradiation of the subcutaneous tissues, such as disclosed in U.S. Pat. No. Re36,903. This procedure is invasive and requires multiple surgical incisions for introduction of the optical fibers under the skin. The fibers deliver pulsed optical radiation that destroys the subcutaneous tissues as the tip of the fiber moves along predetermined lines on the face or neck. Debulking the subcutaneous fat and limited injury to the dermis along the multiple lines of the laser treatment results in contraction of the skin during the healing process, ultimately providing the face lift. The drawback of the method is its high price and possibility of infection.
Electrosurgical devices and methods utilizing high frequency electrical energy to treat a patient's skin, including resurfacing procedures and removal of pigmentation, scars, tattoos and hairs have been developed lately, such as disclosed in U.S. Pat. No. 6,264,652. The principle drawback of this technology is collateral damage to the surrounding and underlying tissues, which can lead to forming scars and skin discoloration.
Other forms of cosmetic surgery are also known. One example is liposuction, which is an invasive procedure that involves inserting a suction device under the skin and removing fat tissues. As with other invasive surgical procedures, there is always a risk of infection. In addition, because of the invasive nature of the procedure, physicians usually try to minimize the number of times the procedure must be performed and thus will remove as much fat tissue as possible during each procedure. Unfortunately, this procedure has resulted in patient deaths when too much tissue was removed. Assuming successful removal of excess fat tissue, further invasive surgery may be required to accomplish desired skin tightening.
The prior art to date, then, does not meet the desired goal of performing cosmetic surgery in a non-invasive manner while causing minimal or no scarring of the exterior surface of the skin and at the same time resulting in the skin tightening.
It is an object of the present invention to provide an apparatus and method which uses electroporation to cause necrosis of cells in the subcutaneous layer of fat and the interior side of the dermis, resulting in the contraction and tightening of the skin. In particular, it is an object of the present invention to provide method and apparatus for performing face and neck lift and others similar procedures on the face in a non-invasive manner.
Another object of the present invention is to provide an apparatus and method for significant bulk reduction of the number of subcutaneous fat cells in the body, resulting in a significant weight loss.
Still another object of the present invention is to provide non-invasive apparatus and method for cosmetic and weight loss procedures.
Still another object of the invention is to provide an apparatus and method for selective removal of fat in different areas to enable changing the shape of the body, or body sculpturing.
The present invention provides an apparatus and method for creation of a controlled injury or alteration to the subcutaneous tissue and/or underside of the dermis, with the following healing process leading to the contraction of the skin; and/or to the controlled destruction of fat cells, leading to their permanent loss. In the present invention the damage to the subcutaneous tissue, underside of the dermis, and/or fat cells is caused by electroporation.
An apparatus in accord with the current invention comprises a voltage pulse generator, an applicator with two or multiple electrodes of different shapes and sizes and a cable connecting the electrodes to the pulse generator. The pulse generator produces set of high voltage pulses of predetermined amplitude, duration and number to cause necrosis in a treated area of subcutaneous tissues.
A method in accord with the current invention comprises application of electrical pulses to the electrodes positioned on the skin in a treatment area. For a face lift, flat and needle-like electrodes are used, the last one providing a strong and non-uniform electric field predominantly normal to the surface of the skin. The amplitude, duration and number of applied pulses are selected to cause necrosis of fat cells to a predetermined depth in the subcutaneous tissue and a limited necrosis of the underside of the dermis. A number of lines of predetermined pattern are exposed to electroporation. Later, during the healing process the skin on the treated area contracts. The injury to the tissues made by electroporation is very gentle and selective; it does not produce scars on the epidermis, the most external layer of the skin.
A method of weight loss and body sculpturing in accord with the present invention comprises application of electroporation pulses to a significant volume of fat tissue. In this case both electrodes are flat and attached to the arms of a forceps. The electrodes are moveable towards and away from each other and are capable of pinching skin with underlying subcutaneous fat and electroporating it. Application of flat, parallel electrodes produces a electric field is uniform in the tissue that effects only fat cells.
For weight loss a voltage generator coupled to multiple needle type electrodes may be used.
In another embodiment of the present invention, an electroporation apparatus for bulk weight loss may comprise apparatus for production of a pulsed magnetic field and its application to the area to be treated. In this embodiment of the present invention, a curl electric field for the electroporation of subcutaneous fat is created by the pulsed magnetic field. Curl electric field causes eddy currents in the tissue and at an appropriate amplitude above kills the fat cells.
The objects and advantages of the present invention will be appreciated from the following specification when read in conjunction with the accompanying drawings wherein:
The term “electroporation” (EP) refers to the use of electric field pulses to induce microscopic pores in the cell membranes called “electropores”. Depending on the parameters of the electric pulse, an electroporated cell can survive the pulse or die. The cause of death of an electroporated cell is believed to be a chemical imbalance, resulting from the fluid communication with the extra cellular environment through the pores. The number and size of electropores created depends on the product of the amplitude E and duration t of the pulse. Below a certain limit, no electropores are induced at all. This limit is different for different cells and depends, principally, on their sizes. The smaller the cell, the higher the product of the amplitude and duration must be to induce pores. Above the lower limit the number of pores and their effective diameter increases with the product Et. Until an upper limit is achieved, cells survive pulsing and restore their viability thereafter. Above the upper limit the pores diameters and number become too large for a cell to survive. It cannot repair itself by any spontaneous or biological process and dies. As noted, a cell's vulnerability to an electric field depends on its size: the larger the cell, the lower the electric field required for killing it. If cells of different sizes are exposed to the same electric field, the largest cells are the first to die. Thus, application of an electric field having preselected parameters can result in selectively killing particular cells.
A desirable target for cell death using the present invention is adipose tissue, commonly called fat. Adipose cells do not proliferate in adults. Their number is fixed at a very early age. Adipose cells can change their size by accumulating or loosing lipids and be responsible for significant, up to two-fold increase in the body weight. Cutting down in the number of large adipose cells results in a significant weight loss in the fat tissue and the whole body. If fat cells are destroyed by any means, their content is metabolized by the body, i.e., scavenged by macrophages, and their number is not restored. The loss of adipose cells, then, is permanent.
Adipose tissue consists of lipid-filled cells ranging in size from 25 to 200 microns. An applied electric field affects the various sized cells differently as previously mentioned. For example, if an electric field, equal to the upper electroporation limit for 100 micron cells (about 10-20 V/mm) is applied to a fat tissue, all cells with sizes from 100 micron and above, will die. The dead cells will be disposed later by macrophages, and the body will metabolize the lipids stored in these cells. Small adipose cells, for which the applied electric field is below the upper electroporation limit, survive any number of electric pulses without any morphological or functional damage.
Pulsed electric fields can be applied to fat deposits inside the body by different methods. In a first method two electrodes are applied to the skin over the fat tissue at some distance from each other and electric microsecond pulses are applied by the electrodes to the tissue. The pulse electric field, created by these two electrodes is non-uniform; it is higher near the electrodes and decreases with the depth. The electric field at the fat deposits should reach several tens of volts per mm to be able to kill adipose cells of large diameters. At the skin level the non-uniform electric field will be significantly higher. To be harmless for the skin cells, the field should not exceed the value of the upper electroporation limit for skin cells. The cells in the epidermic basal layer of the skin, which is responsible for the mitotic division and continuous rejuvenation of the skin, have dimensions of about 10 microns or less (6-10 microns). This is 10 or more times less than that of the targeted adipose cells, which is about 100 microns and larger as noted earlier. The upper electroporation limit for the skin cells in accordance with their size is therefore about 10 times higher than that of adipose cells of 100 microns diameter.
A second method of applying an electric field to the subcutaneous adipose tissue or the skin is by applying short magnetic pulses preferentially normally to the skin. The transient magnetic field creates curl electric field in the skin and the underlying tissues. This curl electric field causes eddy currents in the cells. If the magnitude of this transient electric field reaches the upper electroporation limit for the cells, it will kill them exactly as does the potential electric field created by charged electrodes.
The depth of penetration of the electric field in the skin and the fat tissue under it depends on the distance between the electrodes, their shape and size. The larger the size of electrodes and the distance between them, the deeper the penetration will be. If the electrodes are small enough and the distance between them is short, the electric field penetrates only into the skin and does not reach the underlying tissues.
If pulsed electric field penetrates only in the skin and its amplitude is high enough to kill skin cells (several hundred volts per mm), electroporation can be used for selective cell killing. The dead cells are removed by macrophages and the skin shrinks during the healing process. This skin shrinkage can be planned in advance both in terms of directions and degree. By selecting a number, direction and length of the electroporation “cuts” the operator can control the future shrinks. This method can be used for correcting wrinkles and skin pouches on the face, the neck, and on the upper and lower eye lids.
The skin electroporation treatment together with fat reducing electroporation treatment can be used as alternative to cosmetic surgery for the face lift, the upper and lower eye lid surgery, the forehead lift and body sculpturing practically in all parts of the human body.
An electroporation treatment presents several notable advantages over present cosmetic surgery procedures. First, an electroporation treatment is sterile. The most upper layer of the skin, comprising horny dead cells, is very resistant to any damage from an electroporation treatment; it protects the lower layers of the skin from infection.
The electroporation virtual facelift and body sculpturing can be performed in step by step fashion in a multi-session process. This method allows taking into account actual results of previous sessions and directs process of reshaping of the face or body to desired objectives. The treatment can be performed by a medical professional or by the patient him/herself.
With the foregoing generalized explanation of the present invention, apparatus in accord therewith may be described. Referring to
In
In
The present invention having thus been described, other modifications, alterations, or substitutions may now suggest themselves to those skilled in the art, all of which are within the spirit and scope of the present invention. It is therefore intended that the present invention be limited only by the scope of the attached claims below.
This is a continuation of U.S. application Ser. No. 14/176,889, filed Feb. 10, 2014, now U.S. Pat. No. 8,906,006, which is a continuation of U.S. application Ser. No. 13/556,455, filed Jul. 24, 2012, now U.S. Pat. No. 8,647,338, which is a continuation of U.S. application Ser. No. 12/501,225, filed Jul. 10, 2009, now U.S. Pat. No. 8,251,986, which is a continuation of U.S. application Ser. No. 11/106,835, now U.S. Pat. No. 7,938,824, filed Apr. 15, 2005, which is a continuation of U.S. application Ser. No. 09/931,672, filed Aug. 17, 2001, now U.S. Pat. No. 6,892,099, which claims priority to U.S. provisional application Ser. No. 60/267,106, filed Feb. 8, 2001 and to U.S. provisional application Ser. No. 60/225,775, filed Aug. 17, 2000, all of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1653819 | Northcott et al. | Dec 1927 | A |
3730238 | Butler | May 1973 | A |
3746004 | Jankelson | Jul 1973 | A |
3871359 | Pacela | Mar 1975 | A |
4016886 | Doss et al. | Apr 1977 | A |
4037341 | Odle et al. | Jul 1977 | A |
4216860 | Heimann | Aug 1980 | A |
4226246 | Fragnet | Oct 1980 | A |
4262672 | Kief | Apr 1981 | A |
4267047 | Henne et al. | May 1981 | A |
4278092 | Borsanyi et al. | Jul 1981 | A |
4299217 | Sagae et al. | Nov 1981 | A |
4311148 | Courtney et al. | Jan 1982 | A |
4336881 | Babb et al. | Jun 1982 | A |
4344436 | Kubota | Aug 1982 | A |
4392855 | Oreopoulos et al. | Jul 1983 | A |
4406827 | Carim | Sep 1983 | A |
4407943 | Cole et al. | Oct 1983 | A |
4416276 | Newton et al. | Nov 1983 | A |
4447235 | Clarke | May 1984 | A |
4469098 | Davi | Sep 1984 | A |
4489535 | Veltman | Dec 1984 | A |
4512765 | Muto | Apr 1985 | A |
4580572 | Granek et al. | Apr 1986 | A |
4636199 | Victor | Jan 1987 | A |
4672969 | Dew | Jun 1987 | A |
4676258 | Inokuchi et al. | Jun 1987 | A |
4676782 | Yamamoto et al. | Jun 1987 | A |
4687471 | Twardowski et al. | Aug 1987 | A |
4716896 | Ackerman | Jan 1988 | A |
4723549 | Wholey et al. | Feb 1988 | A |
D294519 | Hardy, Jr. | Mar 1988 | S |
4756838 | Veltman | Jul 1988 | A |
4772269 | Twardowski et al. | Sep 1988 | A |
4798585 | Inoue et al. | Jan 1989 | A |
4810963 | Blake-Coleman et al. | Mar 1989 | A |
4813929 | Semrad | Mar 1989 | A |
4819637 | Dormandy, Jr. et al. | Apr 1989 | A |
4822470 | Chang | Apr 1989 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4840172 | Augustine et al. | Jun 1989 | A |
4863426 | Ferragamo et al. | Sep 1989 | A |
4885003 | Hillstead | Dec 1989 | A |
4886496 | Conoscenti et al. | Dec 1989 | A |
4886502 | Poirier et al. | Dec 1989 | A |
4889634 | El-Rashidy | Dec 1989 | A |
4907601 | Frick | Mar 1990 | A |
4919148 | Muccio | Apr 1990 | A |
4920978 | Colvin | May 1990 | A |
4921484 | Hillstead | May 1990 | A |
4946793 | Marshall, III | Aug 1990 | A |
4976709 | Sand | Dec 1990 | A |
4981477 | Schon et al. | Jan 1991 | A |
4986810 | Semrad | Jan 1991 | A |
4987895 | Heimlich | Jan 1991 | A |
5019034 | Weaver et al. | May 1991 | A |
5031775 | Kane | Jul 1991 | A |
5052391 | Silberstone et al. | Oct 1991 | A |
5053013 | Ensminger et al. | Oct 1991 | A |
5058605 | Slovak | Oct 1991 | A |
5071558 | Itoh | Dec 1991 | A |
5098843 | Calvin | Mar 1992 | A |
5122137 | Lennox | Jun 1992 | A |
5134070 | Casnig | Jul 1992 | A |
5137517 | Loney et al. | Aug 1992 | A |
5141499 | Zappacosta | Aug 1992 | A |
D329496 | Wotton | Sep 1992 | S |
5156597 | Verreet et al. | Oct 1992 | A |
5173158 | Schmukler | Dec 1992 | A |
5186715 | Phillips et al. | Feb 1993 | A |
5186800 | Dower | Feb 1993 | A |
5188592 | Hakki | Feb 1993 | A |
5190541 | Abele et al. | Mar 1993 | A |
5192312 | Orton | Mar 1993 | A |
5193537 | Freeman | Mar 1993 | A |
5209723 | Twardowski et al. | May 1993 | A |
5215530 | Hogan | Jun 1993 | A |
5222997 | Montgomery | Jun 1993 | A |
5224933 | Bromander | Jul 1993 | A |
5227730 | King et al. | Jul 1993 | A |
5242415 | Kantrowitz et al. | Sep 1993 | A |
5273525 | Hofmann | Dec 1993 | A |
D343687 | Houghton et al. | Jan 1994 | S |
5277201 | Stern | Jan 1994 | A |
5279564 | Taylor | Jan 1994 | A |
5281213 | Milder et al. | Jan 1994 | A |
5283194 | Schmukler | Feb 1994 | A |
5290263 | Wigness et al. | Mar 1994 | A |
5308325 | Quinn et al. | May 1994 | A |
5308338 | Helfrich | May 1994 | A |
5318543 | Ross et al. | Jun 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5328451 | Davis et al. | Jul 1994 | A |
5334167 | Cocanower | Aug 1994 | A |
D351661 | Fischer | Oct 1994 | S |
5383917 | Desai et al. | Jan 1995 | A |
5389069 | Weaver | Feb 1995 | A |
5391158 | Peters | Feb 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5405320 | Twardowski et al. | Apr 1995 | A |
5417687 | Nardella et al. | May 1995 | A |
5425752 | Vu'Nguyen | Jun 1995 | A |
5439440 | Hofmann | Aug 1995 | A |
5439444 | Andersen et al. | Aug 1995 | A |
5458597 | Edwards et al. | Oct 1995 | A |
5458625 | Kendall | Oct 1995 | A |
5462521 | Brucker et al. | Oct 1995 | A |
5484400 | Edwards et al. | Jan 1996 | A |
5484401 | Rodriguez et al. | Jan 1996 | A |
5533999 | Hood et al. | Jul 1996 | A |
5536240 | Edwards et al. | Jul 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5540737 | Fenn | Jul 1996 | A |
5546940 | Panescu et al. | Aug 1996 | A |
5562720 | Stern et al. | Oct 1996 | A |
5575811 | Reid et al. | Nov 1996 | A |
D376652 | Hunt et al. | Dec 1996 | S |
5582588 | Sakurai et al. | Dec 1996 | A |
5586982 | Abela | Dec 1996 | A |
5588424 | Insler et al. | Dec 1996 | A |
5588960 | Edwards et al. | Dec 1996 | A |
5599294 | Edwards et al. | Feb 1997 | A |
5599311 | Raulerson | Feb 1997 | A |
5616126 | Malekmehr et al. | Apr 1997 | A |
5620479 | Diederich | Apr 1997 | A |
5626146 | Barber et al. | May 1997 | A |
5630426 | Eggers et al. | May 1997 | A |
D380272 | Partika et al. | Jun 1997 | S |
5634899 | Shapland et al. | Jun 1997 | A |
5643197 | Brucker et al. | Jul 1997 | A |
5645855 | Lorenz | Jul 1997 | A |
5672173 | Gough et al. | Sep 1997 | A |
5672174 | Gough et al. | Sep 1997 | A |
5674267 | Mir et al. | Oct 1997 | A |
5683384 | Gough et al. | Nov 1997 | A |
5687723 | Avitall | Nov 1997 | A |
5690620 | Knott | Nov 1997 | A |
5697905 | d'Ambrosio | Dec 1997 | A |
5700252 | Klingenstein | Dec 1997 | A |
5702359 | Hofmann et al. | Dec 1997 | A |
5707332 | Weinberger | Jan 1998 | A |
5718246 | Vona | Feb 1998 | A |
5720921 | Meserol | Feb 1998 | A |
5728143 | Gough et al. | Mar 1998 | A |
5735847 | Gough et al. | Apr 1998 | A |
5752939 | Makoto | May 1998 | A |
5778894 | Dorogi et al. | Jul 1998 | A |
5782827 | Gough et al. | Jul 1998 | A |
5782882 | Lerman et al. | Jul 1998 | A |
5800378 | Edwards et al. | Sep 1998 | A |
5800484 | Gough et al. | Sep 1998 | A |
5807272 | Kun et al. | Sep 1998 | A |
5807306 | Shapland et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5810742 | Pearlman | Sep 1998 | A |
5810762 | Hofmann | Sep 1998 | A |
5810804 | Gough et al. | Sep 1998 | A |
5830184 | Basta | Nov 1998 | A |
5836897 | Sakurai et al. | Nov 1998 | A |
5836905 | Lemelson et al. | Nov 1998 | A |
5843026 | Edwards et al. | Dec 1998 | A |
5843182 | Goldstein | Dec 1998 | A |
5863290 | Gough et al. | Jan 1999 | A |
5865787 | Shapland et al. | Feb 1999 | A |
5866756 | Giros et al. | Feb 1999 | A |
5868708 | Hart et al. | Feb 1999 | A |
5873849 | Bernard | Feb 1999 | A |
5904648 | Arndt et al. | May 1999 | A |
5913855 | Gough et al. | Jun 1999 | A |
5919142 | Boone et al. | Jul 1999 | A |
5919191 | Lennox et al. | Jul 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5944710 | Dev et al. | Aug 1999 | A |
5947284 | Foster | Sep 1999 | A |
5947889 | Hehrlein | Sep 1999 | A |
5954745 | Gertler et al. | Sep 1999 | A |
5957919 | Laufer | Sep 1999 | A |
5968006 | Hofmann | Oct 1999 | A |
5983131 | Weaver et al. | Nov 1999 | A |
5984896 | Boyd | Nov 1999 | A |
5991697 | Nelson et al. | Nov 1999 | A |
5999847 | Elstrom | Dec 1999 | A |
6004339 | Wijay | Dec 1999 | A |
6009347 | Hofmann | Dec 1999 | A |
6009877 | Edwards | Jan 2000 | A |
6010613 | Walters et al. | Jan 2000 | A |
6012885 | Taylor et al. | Jan 2000 | A |
6016452 | Kasevich | Jan 2000 | A |
6029090 | Herbst | Feb 2000 | A |
6041252 | Walker et al. | Mar 2000 | A |
6043066 | Mangano et al. | Mar 2000 | A |
6050994 | Sherman | Apr 2000 | A |
6055453 | Hofmann et al. | Apr 2000 | A |
6059780 | Gough et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6068121 | McGlinch | May 2000 | A |
6068650 | Hofmann et al. | May 2000 | A |
6071281 | Burnside et al. | Jun 2000 | A |
6074374 | Fulton | Jun 2000 | A |
6074389 | Levine et al. | Jun 2000 | A |
6085115 | Weaver et al. | Jul 2000 | A |
6090016 | Kuo | Jul 2000 | A |
6090105 | Zepeda et al. | Jul 2000 | A |
6090106 | Goble et al. | Jul 2000 | A |
6102885 | Bass | Aug 2000 | A |
20010044596 | Jaafar | Nov 2001 | A1 |
Number | Date | Country |
---|---|---|
2297846 | Feb 1999 | CA |
4000893 | Jul 1991 | DE |
0218275 | Apr 1987 | EP |
0339501 | Nov 1989 | EP |
0378132 | Jul 1990 | EP |
0528891 | Mar 1993 | EP |
0533511 | Mar 1993 | EP |
0935482 | Aug 1999 | EP |
WO9104014 | Apr 1991 | WO |
WO9634571 | Nov 1996 | WO |
WO9639531 | Dec 1996 | WO |
WO9810745 | Mar 1998 | WO |
WO9814238 | Apr 1998 | WO |
WO9901076 | Jan 1999 | WO |
WO9904710 | Feb 1999 | WO |
WO0020554 | Apr 2000 | WO |
Entry |
---|
Cowley, Lifestyle Good news for boomers, Newsweek, Dec. 30, 1996. |
Sharma, et al, Poloxamer 188 decrease susceptibility of artificial lipid membranes to electroporation, Biophysical Journal, 1996, vol. 71, pp. 3229-3241. |
Blad, Baldetorp, Impedance spectra of tumour tissue in comparison with normal tissue; a possible clinical application for electrical impedance tomography, Physiol. Meas., 1996, 17, pp. A105-A115. |
Ho, Mittal, Electroporation of cell membranes: a review, Critical Reviews in Biotechnology, 1996, 16(4), pp. 349-362. |
Gilbert, et al, Rapid report novel electrode designs for electrochemotherapy, Biochimica et Biophysica Acta, Feb. 11, 1997, 1134, pp. 9-14. |
Zlotta, et al, Possible mechanisms fo action of transsurethral needle ablation of the prostate on benign prostatic hyperplasia systems: A neurohistochemical study, Journal of Urology, Mar. 1997, vol. 157, No. 3, pp. 894-899. |
Duraiswami et al, Solution of electrical impedance tomography equations using boundary element methods, Boundary Element Technology XII, Apr. 1997, pp. 227-237. |
Naslund, Transurethral needle ablation of the prostate, Urology, Aug. 1997, vol. 50, No. 2, pp. 167-172. |
Boone, et al, Review imaging with electricity: Report of the European concerted action on impedance tomography, Journal of Medical Engineering & Technology, Nov. 1997, vol. 21, No. 6, pp. 201-232. |
Lurquin, Review: Gene transfer by electroporation, Molecular Biotechnology, 1997, vol. 7, pp. 5-31. |
Hapala, Breaking the barrier: methods for reversible permeabilization of cellular membranes, Critical Reviews in Biotechnology, 1997, 17(2), pp. 105-122. |
Duraiswami, et al, Boundary element techniques for efficient 2-D and 3-D electrical impedance tomography, Chemical Engineering Science, 1997, vol. 52, No. 13, pp. 2185-2196. |
Pinero, et al, Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells, Apoptosis, 1997, 2, pp. 330-336. |
Miklavcic, et al, The importance of electric field distribution for effective in vivo electroporation of tissues, Biophysical Journal, May 1998, vol. 74, pp. 2152-2158. |
Issa, et al, Recent Reports: The TUNA procedure for BPH: Review of the technology, Infections in Urology, Jul. 1998. |
Lundqvist, et al, Altering the biochemical state of individual cultured cells and organelles with ultramicroelectrodes, Proc. Natl. Acad. Sci. USA, Sep. 1998, Vo. 95, pp. 10356-10360. |
Issa, et al, Specialty Surgery: The TUNA procedure for BPH: Basic procedure and clinical results, Infections in Urology, Sep. 1998. |
Dev, et al, Sustained local delivery of heparin to the rabbit arterial wall with an electroporation catheter, Catheterization and Cardiovascular Diagnosis, 1998, 45, pp. 337-345. |
Duraiswami, et al, Efficient 2D and3D electrical impedance tomography using dual reciprocity boundary element techniques, Engineering Analysis with Boundary Elements, 1998, 22, pp. 13-31. |
Mir, et al, Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy, 1998, British Journal of Cancer, 77 (12), pp. 2336-2342. |
Sersa, et al, Tumor blood flow modifying effect of electrochemotherapy with Bleomycin, Anticancer Research, 1999, 19, pp. 4017-4022. |
Thompson, et al, To determine whether the temperature of 2% lignocaine gel affects the initial discomfort which may be associated with its instillation into the male urethra, BJU International, 1999, 84, pp. 1035-1037. |
Yang, et al, Dielectric properties of human luekocyte subpopulations determined by electrorotation as a cell separation criterion, Jun. 1999, vol. 76, pp. 3307-3014. |
Huang, Rubinsky, Micro-electroporation: improving the efficiency and understanding of electrical permeabilization of cells, Biomedical Microdevices, 1999, 2:2, pp. 145-150. |
Mir, Orlowski, Mechanisms of electrochemotherapy, Advanced Drug Delivery Reviews, 1999, 35, pp. 107-118. |
Jaroszeski, et al, In vivo gene delivery by electroporationi, Advanced Drug Delivery Reviews, 1999, 35, pp. 131-137. |
Gehl, et al, In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution, Biochimica et Biophysica Acta, 1999, 1428, pp. 233-240. |
Heller, et al, Clinical applications of electrochemotherapy, Advanced Drug Delivery Reviews, 1999, 35, 119-129. |
Dev, et al, Medical applications of electroporation, IEEE Transactions on Plasma Science, Feb. 2000, vol. 28, No. 1, pp. 206-222. |
Eppich, et al, Pulsed electric fields for seletion of hematopoietic cells and depletion of tumor cell contaminants, Nature America, Aug. 2000, vol. 18, pp. 882-887. |
Mir, Therapeutic perspectives of in vivo cell electropermeabilization, Bioelectrochemistry, 2000, 53, pp. 1-10. |
Al-Khadra, et al, The role of electroporation in defibrillation, Circulation Research, Oct. 27, 2000, 87, pp. 797-804. |
Miklavcic, et al, A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy, Biochimica et Biophysica Acta, 2000, 1523, pp. 73-83. |
Rubinsky, Cryosurgery, Annu. Rev. Biomed. Eng. 2000, 2, pp. 157-187. |
Jaroszeski, et al, In vivo gene delivery by electroporation, Advanced Drug Delivery Reviews, 1999, 35, pp. 131-137. |
Mir, Orlowski, Introduction: Electropermeabilization as a new drug delivery approach, Methods in Molecular Medicine, 2000, vol. 37, pp. 99-117. |
O'Brien, et al, Investigation of the Alamar Blue (resarzurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, Eur J Biochem, 2000, 267, pp. 5421-5426. |
Neumann, Rosenheck, Permeability changes induced by electric impulses in vesicular membranes, J. Membrane Biol., 1972, 10, pp. 279-290. |
Crowley, Electrical breakdown of bimolecular lipid membranes as an electromechanical instability, Biophysical Journal, 1973, vol. 13, 711-724. |
Zimmerman, et al, Dielectric breakdown of cell membranes, Biophysical Journal, 1974, vol. 14, pp. 881-899. |
Organ, Electrophysiologic principles of radiofrequency lesion making, Appl. Neurophysiol., 1976, 39, pp. 69-76. |
Kinosita, Jr., Tsong, Hemodialysis of human erythrocytes by a transient electric field, Biochemistry, 1977, vol. 74, No. 5, pp. 1923-1927. |
Kinsoita, Jr., Tsong, Formation and resealing of pores of controlled sizes in human erythrocyte membrane, Aug. 1977, vol. 268, pp. 438-441. |
Kinosita, Jr., Tsong, Voltage-induced pore formation and hemolysis of human erythrocytes, Biochimica et Biophysica Acta, 1977, pp. 227-242. |
Baker, Knight, Calcium-dependent exocytosis in bovine adrenal medullary cells with leaky plasma membranes, Nature, Dec. 1978, vol. 276, pp. 620-622. |
Gauger, Bentrup, A study of dielectric membrane breakdown in the Fucus egg, J. Membrane Biol., 1979, 48, pp. 249-264. |
Erez, Shitzer, Controlled destruction and temperature distributions in biological tissues subjected to monactive electrocoagulation, Transactions of theASME, Feb. 1980, vol. 102, pp. 42-49. |
Neumann, et al, Gene transfer into mouse lyoma cells by electroporation in high electric fields, The EMBO Journal, 1982, vol. 1, No. 7, pp. 841-845. |
Seibert, et al, Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice, Cancer Research, May 1983, 43, pp. 2223-2239. |
Brown, Phototherapy of tumors, World J. Surg., 1983, 7, 700-709. |
Onik, et al, Ultraonic characteristics of frozen liver, Cryobiology, 1984, 21, pp. 321-328. |
Gilbert, et al, The use of ultrsound imaging for monitoring cryosurgery, IEEE Frontiers of Engineering and computing in Health Care, 1984, pp. 107-111. |
Onik, et al, Sonographic monitoring of hepatic cryosurgery in an experimental animal model, AJR, May 1985, 144, pp. 1043-1047. |
Griffiths, The importance of phase measurement in e lectrical impedance tomography, Phys. Med. Biol., Nov. 1987, vol. 32, No. 11, pp. 1435-1444. |
Okino, Mohri, Effects of high-voltage electrical impulse and an anticancer drug on in vivo growing tumors, Jpn. J. Cancer Res., Dec. 1987, 78, pp. 1319-1321. |
Kinosita, Jr. et al, Electroporation of cell membrane visualized under a pulsed-laser fluorescence microscope, Biophys. J., Jun. 1988, vol. 53, pp. 1015-1019. |
Amasha, et al, Quantitative assessment of impedance tomography for temperature measurements in microwave hyperthermia, Clin. Phys. Physiol. Meas., 1988, vol. 9, Suppl. A, pp. 49-53. |
Asmai, et al, Dielectric properties of mouse lymphocytes and erythrocytes, Biochimica et Biophysica Acta, 1989, 1010, pp. 49-55. |
Griffiths, Zhang, A dual-frequency electrical impedance tomography system, Phys. Med. Biol., 1989, vol. 34, No. 10, pp. 1465-1476. |
Rowland, et al, Transvenous ablation of atrioventricular conduction with a low energy power source, Br Heart J, 1989, 62, pp. 361-366. |
Marsazalek, et al, Schwan equation and transmembrane potential induced by alternating electric field, Biophysical Journal, Oct. 1990, vol. 58, pp. 1053-1058. |
Tekle, et al, Electroporation by using bipolar oscillating electric field: An improved method for DNA transfection of NIH 3T3 cells, Biochemistry, May 1991, vol. 88, pp. 4230-4234. |
Mir, et al, Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses, Eur. J. Cancer, 1991, vol. 27, No. 1, pp. 68-72. |
Mir, et al, Electrochemotherapy, a novel antitumor treatment: first clinical trial, Cancerology, 1991, 313, pp. 613-618. |
Narayan, Dahiya, Establishment and characterization of a human primay prostatic adenocarcinoma cell line (ND-1_, The Journal of Urology, Nov. 1992, vol. 148, pp. 1600-1604. |
Griffiths, et al, Measurement of pharyngeal transit time by electrical impedance tomography, Clin. Phys. Physiol. Meas., 1993, vol. 13, Suppl. A, pp. 197-200. |
Rols, et al, Highly efficient transfection of mammalian cells by electric field pulses application to large volumes of cell culture by using a flow system, Eur. J. Biochem., 1992, 205, pp. 115-121. |
Brown, et al, Blood flow imaging using electrical impedance tomography, Clin. Phys. Physiol. Meas., 1992, vol. 13, Suppl. A, pp. 175-179. |
Foster, et al, Production of prostatic lesions in canines usign transrectally administered high-intensity focused ultrasound, Eur Urol, 1993, pp. 330-336. |
Shiina, et al, Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients, AJR, May 1993, 160, pp. 1023-1028. |
Salford, et al, A new brain tumour therapy combining bleomycin with in vivo electropermeabilization, Biochemical and Biohysical Research Communications, Jul. 30, 1993, vol. 194, No. pp. 938-943. |
Glidewell, NG, The use of magnetic resonance imaging data and the inclusion of anisotropic regions in electrical impedance tomography, ISA, 1993, pp. 251-257. |
Gascoyne, et al, Membrane changes accompanying the induced differentiation of Friend murine erythroleukemia cells studied by dielectrophoresis, Biochimca et Biophysica Acta, 1993, 1149, pp. 119-126. |
Foster, et al, High-intensity focused ultrsound in the treatment of prostatic disease, Eur Urol, 1993, 23(suppl1), pp. 29-33. |
Andreason, Electroporation as a technique for the ransfer of macromolecules into mamalian cell lines, J. Tiss. Cult. Meth., 1993, 15, pp. 56-62. |
Weaver, Electroporation: A general phenomenon for manipulating cells and tissues, Journal of Cellular Biochemistry, 1993, 51, pp. 426-435. |
Barber, Electrical impedance tomography applied potential tomography, Advances in Biomedical Engineering, 1993, IOS Press, pp. 165-173. |
Cook, et al, ACT3: a high-speed, high-precision electrical impedance tomograph, IEEE Transactions on Biomedical Engineering, 1994, vol. 41, No. 8, pp. 713-722. |
Alberts, et al, Molecular biology of the Cell, Biocchemical education, 1994, 22(3), pp. 164. |
Hughes, et al, An analysis of studies comparing electrical impedance tomography with x-ray videofluoroscopy in the assessment of swallowing, Physiol. Meas. 1994, 15, pp. A199-A209. |
Mazurek, et al, Effect of Short HV Pulses in Bacteria and Fungi, 1995, vol. 2, No. 3, pp. 418-425. |
Griffiths, Tissue spectroscopy with electrical impedance tomography: Computer simulations, IEEE Transactions on Biomedical Engineering, Sep. 1995, vol. 42, No. 9, pp. 948-954. |
Gencer, et al, Electrical impedance tomography: Induced-currentimaging achieved with a multiple coil system, IEEE Transactions on Biomedical Engineering, Feb. 1996, vol. 43, No. 2, pp. 139-149. |
Weaver, Chizmadzhev, Theory of electroporation: a review, Biolectrochemistry and Bioenergetics, 1996, vol. 41, pp. 135-160. |
Gimsa, et al, Dielectric spectroscopy of single human erythrocytes at physiological ionic strength: Dispersion of the cytoplasm, Biophysical Journal, Jul. 1996, vol. 71, pp. 495-506. |
Number | Date | Country | |
---|---|---|---|
20160338761 A1 | Nov 2016 | US |
Number | Date | Country | |
---|---|---|---|
60267106 | Feb 2001 | US | |
60225775 | Aug 2000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14535762 | Nov 2014 | US |
Child | 14851508 | US | |
Parent | 14176889 | Feb 2014 | US |
Child | 14535762 | US | |
Parent | 13556455 | Jul 2012 | US |
Child | 14176889 | US | |
Parent | 12501225 | Jul 2009 | US |
Child | 13556455 | US | |
Parent | 11106835 | Apr 2005 | US |
Child | 12501225 | US | |
Parent | 09931672 | Aug 2001 | US |
Child | 11106835 | US |